Table 1.
The effects of NADA and NAGly on the kinetics of CaV3 channels
CaV channel |
Time to peak (ms) |
Deactivation τ (ms) |
||||
---|---|---|---|---|---|---|
Control | NADA | NAGly | Control | NADA | NAGly | |
3.1 | 7.2 ± 0.3 | 6.2 ± 0.3 | 7.3 ± 0.3 | 3.2 ± 0.1 | 3.1 ± 0.1 | 3.2 ± 0.2 |
3.2 | 11.2 ± 0.4 | 11.5 ± 0.6 | 11.6 ± 0.4 | 3.1 ± 0.2 | 3.1 ± 0.2 | 3.1 ± 0.2 |
3.3 | 43 ± 1 | 44 ± 2 | 43 ± 2 | 2.4 ± 0.1 | 2.4 ± 0.2 | 2.3 ± 0.1 |
Cells expressing recombinant CaV3 channels were voltage clamped at −86 mV and then stepped to −26 mV. For examples of these experiments see Figures 2 and 3. The time to peak was measured directly and the decay of the current following repolarization of the membrane to −86 mV fit with a single exponential function. The concentration of NADA was 300 nmol·L−1 for CaV3.1 and CaV3.3 and 1 µmol·L−1 for CaV3.2. 10 µmol·L−1 NAGly was used for each channel. There were no differences in time to peak or deactivation for any current with either drug (paired t-test vs. predrug values for each cell). n = 6–8 for each condition.
NADA, N-arachidonoyl dopamine; NAGly, N-arachidonoyl glycine.